Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Delayed fontanelle closure, when the soft spot on a baby's skull stays open beyond roughly 18 to 24 months, often signals a problem with bone mineralisation, such as rickets from vitamin D, calcium, or phosphate deficiency, though hypothyroidism, Down syndrome, hydrocephalus, achondroplasia, and rarer conditions like cleidocranial dysplasia or hypophosphatasia can also be responsible. Poor mineralisation may show up alongside other clues, including bowed legs, a beaded ribcage, wrist and ankle swelling, delayed teething, frequent fractures, slow growth, or late motor milestones, and blood tests plus X-rays are typically used to confirm the cause. Because a wide, late-closing fontanelle can be a harmless variation in some children and a treatable metabolic or hormonal disorder in others, there are several important factors to weigh before assuming it is nothing, and these are explained in the complete answer below.
Since timing, nutrition, and accompanying symptoms all change what this finding means, a structured review of the full picture is far more useful than matching a single sign. Take a free, instant, online symptom check to organise what you are seeing and understand which next steps and specialist conversations make sense.
Last reviewed for medical accuracy: 08/18/2026
Delayed closure of the fontanelle—sometimes called the “soft spot” on a baby’s head—can be a normal variant, but it may also signal underlying issues with bone mineralisation or metabolic health. Understanding when to monitor, investigate, or treat delayed fontanelle closure helps parents and caregivers take timely action without undue worry.
At birth, the skull is made of several bony plates separated by soft, fibrous gaps called fontanelles. These gaps:
There are two main fontanelles:
The anterior fontanelle typically closes between 9 and 18 months of age. When it remains open much beyond 18–24 months, it is considered delayed.
“Delayed closure of fontanelle” usually means:
Key points:
Bone mineralisation is the process by which calcium, phosphate, and other minerals deposit on a collagen scaffold to harden bone. Inadequate mineralisation can:
Factors influencing mineralisation include:
Rickets (Nutritional or Vitamin-D Resistant)
Congenital Hypothyroidism
Genetic Syndromes
Metabolic Bone Diseases
Hydrocephalus
Malnutrition or Chronic Illness
Delayed fontanelle closure alone isn’t always a red flag. Watch for these accompanying signs:
If any of these appear, further evaluation is warranted.
A pediatrician or pediatric endocrinologist will typically:
Take a detailed history
Perform a physical exam
Order laboratory tests
Obtain imaging studies
Managing delayed closure of fontanelle focuses on correcting the underlying issue:
Nutritional Support
Medical Therapy
Monitoring and Follow-Up
Surgical Intervention
Parents and caregivers can take proactive steps:
It’s natural to feel worried if a soft spot stays open longer than expected. Most children with mild delays grow and develop normally once the underlying cause is identified and treated. Clear communication with healthcare providers helps keep everyone on the same page.
If you notice your child’s fontanelle remains open well past the typical age, or if they show any concerning symptoms, it’s a good idea to take action:
Always discuss any potentially life-threatening or serious concerns with a qualified healthcare professional.
Delayed closure of fontanelle often has a straightforward explanation and is treatable once the root cause—whether nutritional, hormonal or genetic—is identified. Timely evaluation and appropriate management support normal bone mineralisation and healthy development. Remember, you’re not alone: healthcare teams, support networks and reliable tools like the Ubie Symptom Checker can help you navigate each step confidently. If you’re ever uncertain or face serious symptoms, speak to a doctor right away.
(References)
* Tan KL. Wide sutures and large fontanels in the newborn. Am J Dis Child. 1976 Apr;130(4):386-90. doi: 10.1001/archpedi.1976.02120050044007. PMID: 1266823.
* Mau U, Kendziorra H, Kaiser P, Enders H. Restrictive dermopathy: report and review. Am J Med Genet. 1997 Aug 8;71(2):179-85. doi: 10.1002/(sici)1096-8628(19970808)71:2<179::aid-ajmg11>3.0.co;2-b. PMID: 9217218.
* Morava E, Kárteszi J, Weisenbach J, Caliebe A, Mundlos S, Méhes K. Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia. Eur J Pediatr. 2002 Nov;161(11):619-22. doi: 10.1007/s00431-002-0977-x. Epub 2002 Oct 9. PMID: 12424590.
* Al-Gazali LI, Jehier K, Nazih B, Abtin F, Haas D, Sadagahatian R. Further delineation of Raine syndrome. Clin Dysmorphol. 2003 Apr;12(2):89-93. doi: 10.1097/00019605-200304000-00003. PMID: 12868469.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Machol K, Mendoza-Londono R, Lee B. Cleidocranial Dysplasia Spectrum Disorder. 1993. PMID: 20301686.
* Xue Y, Cai T, Shi S, Wang W, Zhang Y, Mao T, Duan X. Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis. 2011 May 10;6:20. doi: 10.1186/1750-1172-6-20. Epub 2011 May 10. PMID: 21569238; PMCID: PMC3113317.
* McElderry JD, Zhao G, Khmaladze A, Wilson CG, Franceschi RT, Morris MD. Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures. J Bone Miner Res. 2013 Aug;28(8):1846-54. doi: 10.1002/jbmr.1924. PMID: 23505073; PMCID: PMC3720727.
* Lally S, Walsh N, Kenny J, Franklin O, Cotter M, Richardson S, McEligott F, Finan A. Fontaine progeroid syndrome-A case report. Clin Case Rep. 2022 Sep;10(9):e6291. doi: 10.1002/ccr3.6291. Epub 2022 Sep 6. PMID: 36093452; PMCID: PMC9448962.
* Jin R, Zhang H, Lin C, Guo J, Zou W, Chen Z, Liu H. Inhibition of miR338 rescues cleidocranial dysplasia in Runx2 mutant mice partially via the Hif1a-Vegfa axis. Exp Mol Med. 2023 Jan;55(1):69-80. doi: 10.1038/s12276-022-00914-w. Epub 2023 Jan 4. PMID: 36599929; PMCID: PMC9898552.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Kosho T, Yamaguchi T, Mizumoto S, Mendoza-Londono R. Musculocontractural Ehlers-Danlos Syndrome. 1993. PMID: 40373179.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.